These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11209024)

  • 21. Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population.
    Chen F; Li YM; Yang LQ; Zhong CG; Zhuang ZX
    IUBMB Life; 2016 Jul; 68(7):516-25. PubMed ID: 27192959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic analysis of nitric oxide and endothelin in end-stage renal disease.
    Freedman BI; Yu H; Anderson PJ; Roh BH; Rich SS; Bowden DW
    Nephrol Dial Transplant; 2000 Nov; 15(11):1794-800. PubMed ID: 11071967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.
    El-Din Bessa SS; Hamdy SM
    Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Mohamed MB; Mahjoub T; Kacem M; Almawi WY
    J Diabetes Complications; 2008; 22(5):331-8. PubMed ID: 18413207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NOS3 894G>T polymorphism is associated with progression of kidney disease and cardiovascular morbidity in type 2 diabetic patients: NOS3 as a modifier gene for diabetic nephropathy?
    Kuricová K; Tanhäuserová V; Pácal L; Bartáková V; Brožová L; Jarkovský J; Kaňková K
    Kidney Blood Press Res; 2013; 38(1):92-8. PubMed ID: 24603156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A common Glu298-->Asp (894G-->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes.
    Cai H; Wang X; Colagiuri S; Wilcken DE
    Diabetes Care; 1998 Dec; 21(12):2195-6. PubMed ID: 9839121
    [No Abstract]   [Full Text] [Related]  

  • 27. Microfluidic chip-based method for genotyping microsatellites, VNTRs and insertion/deletion polymorphisms.
    Sohni YR; Burke JP; Dyck PJ; O'Kane DJ
    Clin Biochem; 2003 Feb; 36(1):35-40. PubMed ID: 12554058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial nitric oxide synthase (ecNOS) 4 a/b gene polymorphism and carotid artery intima-media thickness in type-1 diabetic patients.
    Frost D; Chitu J; Meyer M; Beischer W; Pfohl M
    Exp Clin Endocrinol Diabetes; 2003 Feb; 111(1):12-5. PubMed ID: 12605344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial nitric oxide synthase gene polymorphisms and renal responsiveness to RAS inhibition therapy in type 2 diabetic Asian Indians.
    Cheema BS; Kohli HS; Sharma R; Bhansali A; Khullar M
    Diabetes Res Clin Pract; 2013 Mar; 99(3):335-42. PubMed ID: 23260854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic nephropathy: the ACE hypothesis.
    Marre M
    J Diabetes Complications; 1996; 10(3):126-8. PubMed ID: 8807455
    [No Abstract]   [Full Text] [Related]  

  • 31. -to: Pinizzotto M, Castillo E, Fiaux M, Temier E, Gaillard RC, Ruiz J (2001) Paraoxanase 2 polymorphisms are associated with diabetic nephropathy in Type II diabetes. Diabetologia 44: 104-107.
    Hodgkinson AD; Millward BA; Demaine AG
    Diabetologia; 2002 Jun; 45(6):933-5. PubMed ID: 12154776
    [No Abstract]   [Full Text] [Related]  

  • 32. [Distribution of polymorphism in endothelial nitric oxide synthase gene in Singapore Chinese and its association with diabetic nephropathy].
    Dong JJ; Zhao JJ; Lee KO; Lir MC; Chan SW; Liao L
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3415-7. PubMed ID: 18476541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY; Chen LS; Zhang LC; Zhou TB
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of a missense Glu298Asp mutation of the endothelial nitric oxide synthase gene with end stage renal disease.
    Suzuki H; Nagase S; Kikuchi S; Wang Y; Koyama A
    Clin Chem; 2000 Nov; 46(11):1858-60. PubMed ID: 11067831
    [No Abstract]   [Full Text] [Related]  

  • 35. Association between endothelial nitric oxide synthase Glu298Asp gene polymorphism and diabetic nephropathy susceptibility.
    Zhou TB; Xu HL; Yin SS
    Ren Fail; 2013; 35(1):173-8. PubMed ID: 23113598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese].
    Sun J; Xu Y; Zhu Y
    Zhonghua Nei Ke Za Zhi; 2001 Aug; 40(8):529-32. PubMed ID: 11718053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular endothelial NOS (eNOS) expression in type 2 diabetic patients with nephropathy.
    Komers R; Anderson S
    Nephrol Dial Transplant; 2008 Sep; 23(9):3037; author reply 3037-8. PubMed ID: 18596128
    [No Abstract]   [Full Text] [Related]  

  • 38. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus.
    Mizuiri S; Hemmi H; Inoue A; Yoshikawa H; Tanegashima M; Fushimi T; Ishigami M; Amagasaki Y; Ohara T; Shimatake H
    Nephron; 1995; 70(4):455-9. PubMed ID: 7477652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome.
    Monti LD; Barlassina C; Citterio L; Galluccio E; Berzuini C; Setola E; Valsecchi G; Lucotti P; Pozza G; Bernardinelli L; Casari G; Piatti P
    Diabetes; 2003 May; 52(5):1270-5. PubMed ID: 12716763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dinucleotide repeat polymorphisms in EDN1 and NOS3 are not associated with severe diabetic retinopathy in type 1 or type 2 diabetes.
    Warpeha KM; Ah-Fat F; Harding S; Patterson CC; Xu W; Hart PM; Chakravarthy U; Hughes AE
    Eye (Lond); 1999 Apr; 13 ( Pt 2)():174-8. PubMed ID: 10450377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.